文献速递细胞病理与分子病理胸部病理

胸腺肿瘤细针穿刺诊断的陷阱

Pitfalls of FNA diagnosis of thymic tumors.
PubMed 文献 · Cancer Cytopathol · 2019-11-19

该研究回顾性分析2002年1月至2018年6月MD安德森癌症中心118例胸腺病变FNA病例,与最终组织学诊断对照,93.2%(110例)一致,6.8%(8例)不一致;误判原因包括取样误差、缺乏组织架构信息及富淋巴细胞胸腺瘤与T淋巴母细胞淋巴瘤的细胞学与免疫表型相似。

要点

  • 胸腺肿瘤FNA诊断与最终组织学诊断一致率可达93.2%。
  • 富淋巴细胞胸腺瘤与T淋巴母细胞淋巴瘤的细胞学与免疫表型相似是主要陷阱。
  • 取样误差和缺乏组织架构信息可导致误判,需谨慎处理每例以避免不当治疗。

核心结论

  • 胸腺肿瘤FNA诊断在多数病例中准确,但罕见病例存在诊断陷阱,需谨慎处理以避免误诊导致的不恰当治疗。

研究设计与样本

  • 回顾性检索MD安德森癌症中心病理数据库2002年1月至2018年6月细胞学或对应最终组织学诊断中含「thymoma」或「thymic」的FNA病例,共纳入115例患者的118例FNA病例,并与最终组织学诊断比较。

主要发现

  • 110例(93.2%)FNA诊断与最终病理诊断一致,包括胸腺瘤97例、非典型胸腺瘤5例、胸腺癌8例。
  • 8例(6.8%)FNA与最终诊断不一致:胸腺瘤 vs 非典型胸腺瘤/胸腺癌3例,胸腺瘤 vs 淋巴瘤2例,疑似淋巴瘤 vs 胸腺瘤1例,T淋巴母细胞淋巴瘤 vs 胸腺瘤2例。
  • 误判因素包括FNA样本固有局限(取样误差和缺乏组织架构信息)以及富淋巴细胞胸腺瘤与T淋巴母细胞淋巴瘤在细胞学和免疫表型上的相似性。

临床怎么用

  • 对胸腺病变FNA诊断应警惕富淋巴细胞病变的鉴别陷阱,结合免疫表型并谨慎处理每例,必要时进一步取材以避免误诊导致不恰当治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fine-needle aspiration (FNA), a minimally invasive and cost-effective procedure, often is used in the initial diagnosis of thymic lesions. However, the diagnosis can be challenging. Knowledge of the diagnostic pitfalls is important to improve diagnostic accuracy. METHODS: The authors retrospectively searched the pathology database of The University of Texas MD Anderson Cancer Center for FNA cases using the keywords "thymoma" or "thymic" in cytologic diagnoses or in corresponding final histologic diagnoses rendered from January 2002 to June 2018. The authors reviewed the FNA diagnostic accuracy and pitfalls in comparison with the final histologic diagnoses. RESULTS: A total of 118 FNA cases were identified from 115 patients. The FNA diagnoses were concordant with the final pathologic diagnoses in 110 cases (93.2%), including thymoma (97 cases), atypical thymoma (5 cases), and thymic carcinoma (8 cases). Discrepant FNA and final diagnoses were noted in 8 tumors (6.8%): thymoma versus atypical thymoma/thymic carcinoma (3 tumors), thymoma versus lymphoma (2 tumors), suspicious for lymphoma versus thymoma (1 tumor), and T-lymphoblastic lymphoma versus thymoma (2 tumors). Factors contributing to misinterpretation included intrinsic limitations of the FNA sample (sampling error and a lack of histologic architecture information) and similarities of the cytologic and immunophenotypic features of lymphocyte-rich thymoma and T-lymphoblastic lymphoma. CONCLUSIONS: An accurate FNA diagnosis of thymic tumors can be rendered in the majority of cases. Diagnostic pitfalls can be encountered in rare cases. It is important to handle each case carefully to avoid erroneous diagnoses that may lead to inappropriate treatment.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Wang M, Kundu U, Gong Y, et al. Pitfalls of FNA diagnosis of thymic tumors. Cancer Cytopathol. 2019. PMID: 31742902. doi:10.1002/cncy.22211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。